Release date: 2013-06-14 Duke University Hospital's team of doctors has successfully implanted an artificial bionic blood vessel into a kidney disease patient. It is reported that this artificial blood vessel was cultivated using bioengineering technology, and this operation is also the first successful in the United States. Surgery for implanting artificial bionic blood vessels. Duke University Hospital's team of doctors has successfully implanted an artificial bionic blood vessel into a kidney patient. The patient undergoing surgery was a 62-year-old kidney patient who had been undergoing dialysis for kidney disease for many years, and the artificial blood vessels could speed up blood flow, thus helping the kidney patients to successfully complete the dialysis process. On June 5, after two hours of surgery, the artificial bionic blood vessel was successfully implanted into the patient's body. Since the artificial blood vessel is cultivated using human cells, it will not cause symptoms such as rejection in the patient. The success of this operation indicates that artificial bionic blood vessels have fully met the requirements for clinical use in terms of safety and effectiveness. The technology was jointly developed by Duke University and Humicate. They first cultivated the donor's human cells into a shape of an artificial blood vessel in a specific device, and then removed the blood vessels, which may cause an immune response, thereby achieving implantation into the human body. Claim. "This is a breakthrough in the medical world," said Jeffrey H. Lawson, MD, a vascular surgery and vascular biologist at Duke University School of Medicine. The first human clinical trial of artificial bionic blood vessels was conducted in Poland last December, and the US Food and Drug Administration recently approved a clinical trial for 20 kidney dialysis patients, mainly conducted by researchers at Duke University. . "We hope that the artificial blood vessel we developed can achieve normal growth and integrate with the patient after implantation in the patient," Lawson said. "In fact, the blood vessel is also an organ. If this can be used normally, we will continue in the future. Bioengineering technology will be used to develop organs such as the liver, kidneys and even eyes.†It is also reported that the researchers also plan to apply this artificial bionic blood vessel to heart bypass surgery. Currently, 400,000 patients in the United States need to undergo heart bypass surgery every year. Source: China Daily News Nuts are a group of cleistoses that have a hard skin and contain a single seed. It is the essence of plants, rich in nutrition, containing higher minerals, vitamins, oil and protein, eating more can promote growth and development, increase physical fitness. Common nuts include walnuts, peanuts, almonds, cashews, macadamia nuts, pistachio nuts and so on. Nuts, Almonds,Walnuts,Pistachio nuts,Macadamia nuts Xi'an Gawen Biotechnology Co., Ltd , https://www.agolyn-bio.com